Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
about
Xylotubercidin against herpes simplex virus type 2 in miceEffect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in miceActivity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyesSusceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compoundsBiochemical basis for increased susceptibility to Cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activityMolecular diagnosis of herpes simplex virus infections in the central nervous systemPosttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigsAcyclovir resistance in herpes simplex virus type I encephalitis: a case report.Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.Sexually transmitted diseases in children: herpes simplex virus infection, cytomegalovirus infection, hepatitis B virus infection and molluscum contagiosumSusceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines.Chemotherapy for herpes simplex virus infectionsHerpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapyOrofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses.Resistance of herpesviruses to antiviral drugsAcyclovir prophylaxis for herpes simplex virus infection.Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.Oral acyclovir therapy of genital herpes simplex virus type 2 infections in guinea pigs.Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovirStrategies in the treatment of AIDS and related diseases: the lessons of cancer chemotherapy.Antiviral therapy: current concepts and practicesIsolation and genetic characterization of ethanol-resistant reovirus mutantsEffect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus.Differential effects of acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine on herpes simplex virus and Epstein-Barr virus in a dually infected human lymphoblastoid cell line.Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs.Alterations in substrate specificity and physicochemical properties of deoxythymidine kinase of a drug-resistant herpes simplex virus type 1 mutant.Thymidine plaque autoradiography of thymidine kinase-positive and thymidine kinase-negative herpesviruses.Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.Management of multidrug-resistant viruses in the immunocompromised host.Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates.Penciclovir susceptibilities of herpes simplex virus isolates from patients using penciclovir cream for treatment of recurrent herpes labialis.Biological and biochemical characterization of clinical isolates of herpes simplex virus type 2 resistant to acyclovir.Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates.Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy.Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir.In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus.Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2.
P2860
Q28362158-9B18F3FB-DFAB-4FEB-B285-4F9197F1A2FFQ28365880-D0ECFCD9-F100-4069-B5C4-D773EF4D6FC3Q28366276-3ED32FB2-51D9-4B32-8322-F1666E239E1AQ28367467-AD7C3F96-11BA-48AC-835D-97395B54ED5FQ28378750-2068C5EB-6856-4059-9BBB-5E1D12945C27Q33655137-1FC7D967-91C0-435A-9B8E-7CE7E72A1921Q33758576-4EBE29F8-4875-432B-9CF8-76F6A9FA6369Q33815823-7C0ACC74-F461-4161-90DE-05C85C2BF5FAQ33864322-65E51AAA-BDA8-4D07-898F-4E10F440E218Q33934491-8B20D693-798B-4CC6-81DB-F8612FB3BE3DQ34113580-82164EB1-1785-4EC6-B3B3-B9339D6A2783Q34193041-61CD0C16-34D4-4034-AD51-BC7248F592BFQ34579981-25F02260-CC0A-437B-8FC8-8E41FDA23392Q35244752-714ECDAA-3BFC-4C87-AA95-58A9D664165BQ35354084-E1DE7FA1-2381-4D5A-9606-666E1AEA1A4DQ35447500-0D9194F8-83E8-4387-9B8C-ED9109BBDDCEQ35537506-AC4DD13A-9205-4263-990F-188B6DC7BF66Q35540860-2F5F0A81-9AB2-4CBF-8B03-DA4EBD7F6D55Q35542181-3CF52C96-9CF3-40FF-96D3-5743C46318DFQ35551858-3323F008-8F36-4E58-8C13-0149E91FC7DBQ35569432-A7A94BF5-E546-43AE-891C-D2B0700EEFBCQ35647877-6DD6DC59-DCCD-4876-B9FE-A37D0DAE7E1AQ35930774-0544B077-97A3-4C2C-B8E9-7E1A83C1E582Q36070394-37A896AF-09CC-40A7-B11E-764C91ED346EQ36644956-97293304-6E3B-4564-B155-2E5F9C6C4BCAQ36852791-E0DDB739-0267-4655-AA65-F9E654E3DBB1Q36884995-3C9FC488-785E-49CB-91F0-F7B0E3D35A38Q36903164-A7B37EB4-827A-4290-8C0B-B3A622138FDDQ36932482-13C978C5-DD26-4CB3-9890-5E40B5EA993AQ37302677-51E86EE2-BF04-4DC0-A4BF-EB4175854A99Q37318205-EC420C25-28D1-4A13-B2C7-E84044F27922Q37970424-896A0A35-40B5-4780-8ED3-DC489A05507CQ39463644-53908FEB-D688-4A9D-BF89-FF5B9E2F4499Q39652814-9EDDBEA4-B81D-4B2D-BF7A-5DC93166DA87Q39819155-EDF19519-DD10-4F95-9BC8-A3F3F6C27637Q39850127-574FD55D-8312-4CB6-B75F-CA8E86DB32B1Q39857055-9FB5AC35-BF7D-4AAC-9FBA-210E7E6B4E3DQ39879440-18BE8B39-AA52-4374-886C-5AA9BBB369DDQ40088021-1A7737EA-9BF8-455D-87F1-3C7831ECF858Q40106467-7A6D15A4-E683-4213-B1F8-07B1BFF7476F
P2860
Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh-hant
name
Resistance to antiviral drugs ...... atient treated with acyclovir.
@en
Resistance to antiviral drugs ...... atient treated with acyclovir.
@nl
type
label
Resistance to antiviral drugs ...... atient treated with acyclovir.
@en
Resistance to antiviral drugs ...... atient treated with acyclovir.
@nl
prefLabel
Resistance to antiviral drugs ...... atient treated with acyclovir.
@en
Resistance to antiviral drugs ...... atient treated with acyclovir.
@nl
P2093
P1476
Resistance to antiviral drugs ...... atient treated with acyclovir.
@en
P2093
Crumpacker CS
Hershey BJ
Kowalsky PN
Marlowe SI
Schnipper LE
P304
P356
10.1056/NEJM198202113060606
P407
P577
1982-02-01T00:00:00Z